Medtronic (MDT) Tops Q3 EPS by 2c; offers guidance
Tweet
Share
E-mail
Get Alerts MDT Hot Sheet
Price: $94.17 --0%
Revenue Growth %: +5.3%
Financial Fact:
Amortization Of Intangible Assets: 89M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +5.3%
Financial Fact:
Amortization Of Intangible Assets: 89M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Medtronic (NYSE: MDT) reported Q3 EPS of $1.36, $0.02 better than the analyst estimate of $1.34. Revenue for the quarter came in at $9 billion versus the consensus estimate of $8.91 billion.
GUIDANCE:
Medtronic sees FY2026 EPS of $5.62-$5.66, versus the consensus of $5.65.
For earnings history and earnings-related data on Medtronic (MDT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Downgrades Phreesia Inc. (PHR) to Market Perform
- Holtec Nuclear launches IPO roadshow, targets up to $18 per share
- Ionis Pharmaceuticals (IONS) PT Lowered to $100 at H.C. Wainwright
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
